This pathway has been suggested as a potential target for therapeutic intervention in HCC patients, because it was associated with proliferation induction in HCC, and with sorafenib resistance via AMPK/mTOR signaling pathway [30]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.